Nanoplastics found in the brain raise new aging questions
A Journal of Clinical Investigation viewpoint reports ultra-small nanoplastics in human brain tissue and summarizes laboratory and animal evidence that these particles can interact with amyloid‑beta, tau, and alpha-synuclein, potentially promoting protein aggregation and long-term neurodegenerative aging risk while calling for improved detection methods and exposure research.
Why it mattersJournal of Clinical Investigation findings on nanoplastics interacting with amyloid-beta mean regulators should prioritize tighter plastic-exposure.
Entities Mentioned
Journal of Clinical Investigation